GuidelinesNCT07839546
Adherence to Clinical Guidelines for Management of Patients With Type 2 Diabetes Mellitus and Obesity
An observational study of Guidelines and Diabetes Mellitus Type 2, run by Aristotle University Of Thessaloniki at 1 site in Greece.
Trial summary
Observational study in physicians regarding their adherence to clinical guidelines (by American Diabetes Association 2025) for the management of type 2 diabetes mellitus and obesity via questionnaire Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Guidelines, Diabetes Mellitus Type 2, Obesity Type 2 Diabetes Mellitus
- What is being tested?
- Questionnaire regarding the adherence to American Diabetes Association
- How many people
- 100 participants
- Where
- 1 siteGreece
- Study dates
- 1 Jul 2025to 1 Oct 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: The target population consisted of physicians in Greece who provide care for patients with type two Diabetes Mellitus and obesity, including General Practitioners, Internal Medicine Specialists, Endocrinologists, Resident Doctors and Rural Service Doctors.
Who may be able to join
- Physicians practicing in Greece
- Physicians treating patients with Diabetes Mellitus type 2 and Obesity
Who cannot join
- Non Physicians
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Eleni Karlafti, Assistant Professor MD PhD contact
Greece1 site, 1 recruiting
- Recruiting
Medical School of Aristotle University of Thessaloniki
Thessaloniki, 54646
Triantafyllos Didangelos, Professor MD PhD, +302310994776, didang@auth.gr
Eleni Karlafti, Assistant Professor, linakarlafti@hotmail.com
About this study
Official title: Adherence to Clinical Guidelines for the Management of Patients With Type Two Diabetes Mellitus and Obesity
Observational study in physicians regarding their adherence to clinical guidelines (by American Diabetes Association 2025) for the management of type 2 diabetes mellitus and obesity via questionnaire
Read the detailed description
Our study was an anonymous, questionnaire-based, cross-sectional study utilizing frequency-scale questions. The 2025 American Diabetes Association (ADA) 'Standards of Care in Diabetes' served as the guiding framework for this study, specifically Section 8, titled 'Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes' . An online questionnaire was developed, consisting of questions that assessed the frequency of implementing the ADA guidelines, and was distributed to medical personnel nationwide for completion.
- Conditions
- Guidelines, Diabetes Mellitus Type 2, Obesity Type 2 Diabetes Mellitus, Obesity (BMI > 35) and Diabetes Mellitus
- Being tested
- Questionnaire regarding the adherence to American Diabetes Association
- Keywords
- Guidelines, obesity, diabetes mellitus type 2, physicians
- Medical subject headings
- Diabetes Mellitus, Type 2, Obesity, Diabetes Mellitus
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Questionnaire regarding the adherence to American Diabetes AssociationOther
A questionnaire titled "Physicians' adherence to the current clinical guidelines for the management of patients with type two diabetes mellitus and obesity" was formed, consisting of two sections and 18 closed-ended questions in total. Τhe first part focused on demographics and included four questions, while the second addressed the frequency of adherence to clinical guidelines and consisted of fourteen questions. A 5-point Likert scale, ranging from 'never', 'rarely' (1 - 2 times a month), 'sometimes' (1 - 2 times a week), 'frequently' (3 - 4 times a week) to 'always' (everyday), was used for the 14 questions, aiming to quantify the frequency of implementation. An introductory statement accompanied the questionnaire to provide study details and guarantee anonymous responses.
| Study group | Role | What they receive |
|---|---|---|
| Physicians | Physicians throughout Greece Receives: Other: Questionnaire regarding the adherence to American Diabetes Association |
What is being measured
The primary outcome is the main question the study is designed to answer.
Questionnaire
A questionnaire titled "Physicians' adherence to the current clinical guidelines for the management of patients with type two diabetes mellitus and obesity" was formed, consisting of two sections and 18 closed-ended questions in total. Τhe first part focused on demographics and included four questions, while the second addressed the frequency of adherence to clinical guidelines and consisted of fourteen questions. A 5-point Likert scale, ranging from 'never', 'rarely' (1 - 2 times a month), 'sometimes' (1 - 2 times a week), 'frequently' (3 - 4 times a week) to 'always' (everyday), was used for the 14 questions, aiming to quantify the frequency of implementation. An introductory statement accompanied the questionnaire to provide study details and guarantee anonymous responses
Measured: From start of study (July 2025) until 1 year and half (October 2026)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Sep 2026
- Study start1 Jul 2025
- Primary completion1 Oct 2026 (estimated)
- Study completion1 Oct 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for GuidelinesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Aristotle University Of Thessaloniki
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Prof. Triantafyllos Didangelos, Aristotle University Of Thessaloniki
- Investigators
- Triantafyllos Didangelos, Prof. MD. PhD, Principal investigator, Aristotle University Of Thessaloniki
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07839546
- Sponsor's protocol ID
- 227/2025
- Status last verified
- Sep 2026
- First submitted
- 19 Sep 2026
- Last updated
- 24 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Data protection law in Greece and our bioethics committee approval did not allow sharing of data
Study at a glance
From the registry record, last updated by the sponsor on 24 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Adherence to Clinical Guidelines for the Management of Patients With Type Two Diabetes Mellitus and Obesity
- ClinicalTrials.gov ID
- NCT07839546
- Acronym / sponsor ID
- 227/2025
- Conditions
- Guidelines, Diabetes Mellitus Type 2, Obesity Type 2 Diabetes Mellitus, Obesity (BMI > 35) and Diabetes Mellitus
- Keywords
- Guidelines, obesity, diabetes mellitus type 2, physicians
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Aristotle University Of ThessalonikiUniversity, hospital or other
- Study start
- 1 Jul 2025 (actual)
- Primary completion
- 1 Oct 2026 (estimated)
- Study completion
- 1 Oct 2026 (estimated)
- First posted
- 24 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Observational study in physicians regarding their adherence to clinical guidelines (by American Diabetes Association 2025) for the management of type 2 diabetes mellitus and obesity via questionnaire
Detailed description
Our study was an anonymous, questionnaire-based, cross-sectional study utilizing frequency-scale questions. The 2025 American Diabetes Association (ADA) 'Standards of Care in Diabetes' served as the guiding framework for this study, specifically Section 8, titled 'Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes' . An online questionnaire was developed, consisting of questions that assessed the frequency of implementing the ADA guidelines, and was distributed to medical personnel nationwide for completion.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Physicians | – | Other: Questionnaire regarding the adherence to American Diabetes AssociationPhysicians throughout Greece |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- The target population consisted of physicians in Greece who provide care for patients with type two Diabetes Mellitus and obesity, including General Practitioners, Internal Medicine Specialists, Endocrinologists, Resident Doctors and Rural Service Doctors.
Key inclusion criteria (2 listed)
- Physicians practicing in Greece
- Physicians treating patients with Diabetes Mellitus type 2 and Obesity
Key exclusion criteria (1 listed)
- Non Physicians
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Questionnaire regarding the adherence to American Diabetes AssociationA questionnaire titled "Physicians' adherence to the current clinical guidelines for the management of patients with type two diabetes mellitus and obesity" was formed, consisting of two sections and 18 closed-ended questions in total. Τhe first part focused on demographics and included four questions, while the second addressed the frequency of adherence to clinical guidelines and consisted of fourteen questions. A 5-point Likert scale, ranging from 'never', 'rarely' (1 - 2 times a month), 'sometimes' (1 - 2 times a week), 'frequently' (3 - 4 times a week) to 'always' (everyday), was used for the 14 questions, aiming to quantify the frequency of implementation. An introductory statement accompanied the questionnaire to provide study details and guarantee anonymous responses. | Other | Physicians |
Primary outcome
Questionnaire
Time frame: From start of study (July 2025) until 1 year and half (October 2026)
A questionnaire titled "Physicians' adherence to the current clinical guidelines for the management of patients with type two diabetes mellitus and obesity" was formed, consisting of two sections and 18 closed-ended questions in total. Τhe first part focused on demographics and included four questions, while the second addressed the frequency of adherence to clinical guidelines and consisted of fourteen questions. A 5-point Likert scale, ranging from 'never', 'rarely' (1 - 2 times a month), 'sometimes' (1 - 2 times a week), 'frequently' (3 - 4 times a week) to 'always' (everyday), was used for the 14 questions, aiming to quantify the frequency of implementation. An introductory statement accompanied the questionnaire to provide study details and guarantee anonymous responses
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Sep 2026.
- Individual participant dataSharing planned: No. Data protection law in Greece and our bioethics committee approval did not allow sharing of data
Related trials for Guidelines
RecruitingObservational study
Guideline Implementation and Quality of Care Evaluation in Patients With Heart Failure and Reduced Ejection Fraction (HFrEF)
HFrEF - Heart Failure With Reduced Ejection Fraction, Guideline Adherence
Recruiting
Novel Tools to Improve Management of Paediatric Community-Acquired Pneumonia - ToolCAP
Pneumonia, Pneumonia Childhood
Not yet recruiting
Development of Training Protocol and Application for Speech Language Pathologists on Teletherapy: A Contemporary Approach to Speech Language Therapy
Practice Guideline
Not yet recruiting
Promoting Adherence to Chemotherapy Handling Guidelines Among Oncology Nurses
Chemotherapy Exposure, Handling Guidelines
RecruitingObservational study
Twenty-four Hour Movement Behaviors and Atherosclerotic Risk
Cardiovascular Risk Assessment, Rheumatoid Arthritis (RA)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Eleni Karlafti, Assistant Professor MD PhD contact
Triantafyllos Didangelos, Prof. MD. PhD principal investigator
Aristotle University Of Thessaloniki
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Guidelines and Diabetes Mellitus Type 2, run by Aristotle University Of Thessaloniki at 1 site in Greece.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 24 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Triantafyllos Didangelos Prof. MD PhD, Professor (+302310994776, didang@auth.gr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Questionnaire (time frame: From start of study (July 2025) until 1 year and half (October 2026)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Sep 2026; AzTrials last refreshed its copy on 26 Oct 2026.